Skip to contentC
cbdMD, Inc.
C
YCBDcbdMD, Inc. Q3 2024 · 10-Q
Revenue$5.17M$5.17M−15.5% vs Q3 2023 Net Income$459.74K$459.74KN/M vs Q3 2023 EPS Diluted-$0.15-$0.15N/M vs Q3 2023 Gross Profit$3,403,514−11.5% Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
cbdMD, Inc. · CIK 1644903 · Engraved from SEC EDGAR
Operating Cash Flowderived$289,779N/M Free Cash Flowderived$289,779N/M Margins · derivedGross margin65.8%+2.9 pt vs Q3 2023
Operating margin-7.4%+22.4 pt vs Q3 2023
Net margin8.9%+37.8 pt vs Q3 2023
ended Jun 30, 2024 · filed Aug 14, 2024 · 45 d after period end